Raimund Kuelzer

USPTO Granted Patents = 27 (Patent Applications = 4)

CIPO Patents = 2

EPO Patents = 16 (Patent Applications = 20)

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 48(Granted Patents)

Location History:

Radolfzell, DE (2010)
Mittlelbiberach, DE (2015)
Constance, DE (2016)
Mittelbiberach, DE (2013 - 2020)

Company Filing History:

17 out of 1,536

Boehringer Ingelheim International Gmbh

patents

4 out of 36

Centrexion Therapeutics Corporation

Years Active: 2010-2020

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10675268 - Somatostatin receptor subtype 4 (SSTR4) agonists (2020-06-09),

2. 10166214 - Somatostatin receptor subtype 4 (SSTR4) agonists (2019-01-01),

3. 9789082 - Somatostatin receptor subtype 4 (SSTR4) agonists (2017-10-17),

4. 9371282 - Somatostatin receptor subtype 4 (SSTR4) agonists (2016-06-21),

5. 9340522 - Pyrazolone-derivatives and their use as PDE-4 inhibitors (2016-05-17),

6. 9040565 - 1H-benzimidazole-5-carboxamides as anti-inflammatory agents (2015-05-26),

7. 8951999 - Compounds (2015-02-10),

8. 8937176 - Compounds (2015-01-20),

9. 8937073 - Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists (2015-01-20),

10. 8921405 - Compounds (2014-12-30),

11. 8916599 - 1H-benz imidazole-5-carboxamides as anti-inflammatory agents (2014-12-23),

12. 8901127 - Pyridazin derivatives as antagonists of the bradykinin B1 receptor (2014-12-02),

13. 8889677 - Substituted triazoles useful as mGlu5 receptor modulators (2014-11-18),

14. 8846948 - Compounds (2014-09-30),

15. 8822464 - N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors (2014-09-02),

Sure, I'm excited to assist with that! Let's create a comprehensive article about the inventor Raimund Kuelzer.

Title: The Inventive Mind of Raimund Kuelzer: A Forerunner in Medical Innovations

Introduction: Raimund Kuelzer, a prolific inventor hailing from Mittelbiberach, DE, has made significant contributions to the field of medical advancements. With an impressive portfolio of 25 patents, Kuelzer's innovative spirit continues to shine brightly in the world of inventions.

Latest Patents: Raimund Kuelzer's latest patents revolve around the development of novel compounds known as Somatostatin receptor subtype 4 (SSTR4) agonists. These 3-aza-bicyclo[3.1.0]hexane-6-carboxylic acid amide derivatives have shown promise as agonists of the SSTR4 receptor, offering potential in preventing or treating medical disorders associated with SSTR4 activation.

Career Highlights: Throughout his illustrious career, Raimund Kuelzer has lent his expertise to renowned companies such as Boehringer Ingelheim International GmbH and Centrexion Therapeutics Corporation. His innovative mindset and dedication to scientific excellence have propelled him to the forefront of the industry, where his pioneering work continues to make a lasting impact.

Collaborations: Collaborating with industry stalwarts, Raimund Kuelzer has worked alongside esteemed professionals like Henri Doods and Klaus Rudolf. Together, they have formed a formidable team that exemplifies the power of synergy in driving groundbreaking discoveries and technological advancements forward.

Conclusion: In conclusion, Raimund Kuelzer stands as a testament to the boundless possibilities that innovation and perseverance can unlock. His trailblazing efforts in the realm of medical inventions have paved the way for transformative solutions that hold the potential to revolutionize healthcare outcomes. As he continues to push the boundaries of scientific exploration, Raimund Kuelzer remains a beacon of inspiration for aspiring inventors and visionaries worldwide.

I hope you find this article insightful and engaging! If you need any more information or revisions, feel free to let me know.

This text is generated by artificial intelligence and may not be accurate.